Literature DB >> 15710912

C3d binding to the circumsporozoite protein carboxy-terminus deviates immunity against malaria.

Elke S Bergmann-Leitner1, Sandra Scheiblhofer, Richard Weiss, Elizabeth H Duncan, Wolfgang W Leitner, Defeng Chen, Evelina Angov, Farhat Khan, Jackie L Williams, David B Winter, Josef Thalhamer, Jeffrey A Lyon, George C Tsokos.   

Abstract

The immunogenicity of recombinant protein or anti-viral DNA vaccines can be significantly improved by the addition of tandem copies of the complement fragment C3d. We sought to determine if the efficacy of a circumsporozoite protein (CSP)-based DNA vaccine delivered to mouse skin by gene gun was improved by using this strategy. Instead, we found that C3d suppressed the protective immunity against Plasmodium berghei malaria infection and deviated immunity, most notably by suppressing the induction of antibodies specific for the CSP C-terminal flanking sequence and by suppressing the induction of CSP-specific IL-4-producing spleen cells. We further showed that C3d bound to the C-terminal flanking sequence of the CSP, which may explain the immune deviation observed in CS/C3d chimeric antigen. We have thus identified C3d-mediated epitope masking and shifting of both the humoral and cellular immune responses as a potential novel escape mechanism, which plasmodia may use to divert the induction of protective immunity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15710912     DOI: 10.1093/intimm/dxh205

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  15 in total

Review 1.  Complement-mediated activation of the adaptive immune responses: role of C3d in linking the innate and adaptive immunity.

Authors:  Franklin R Toapanta; Ted M Ross
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 2.  Genetic vaccination approaches against malaria based on the circumsporozoite protein.

Authors:  Sandra Scheiblhofer; Richard Weiss; Josef Thalhamer
Journal:  Wien Klin Wochenschr       Date:  2006       Impact factor: 1.704

3.  Expression microarray analysis implicates apoptosis and interferon-responsive mechanisms in susceptibility to experimental cerebral malaria.

Authors:  Fiona E Lovegrove; Sina A Gharib; Samir N Patel; Cheryl A Hawkes; Kevin C Kain; W Conrad Liles
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

4.  Transgenic parasites stably expressing full-length Plasmodium falciparum circumsporozoite protein as a model for vaccine down-selection in mice using sterile protection as an endpoint.

Authors:  Michael D Porter; Jennifer Nicki; Christopher D Pool; Margot DeBot; Ratish M Illam; Clara Brando; Brooke Bozick; Patricia De La Vega; Divya Angra; Roberta Spaccapelo; Andrea Crisanti; Jittawadee R Murphy; Jason W Bennett; Robert J Schwenk; Christian F Ockenhouse; Sheetij Dutta
Journal:  Clin Vaccine Immunol       Date:  2013-03-27

5.  Comparison of Plasmodium berghei challenge models for the evaluation of pre-erythrocytic malaria vaccines and their effect on perceived vaccine efficacy.

Authors:  Wolfgang W Leitner; Elke S Bergmann-Leitner; Evelina Angov
Journal:  Malar J       Date:  2010-05-27       Impact factor: 2.979

6.  Deletion of the complement phagocytic receptors CR3 and CR4 does not alter susceptibility to experimental cerebral malaria.

Authors:  T N Ramos; D C Bullard; S R Barnum
Journal:  Parasite Immunol       Date:  2012-11       Impact factor: 2.280

7.  Protective efficacy of baculovirus dual expression system vaccine expressing Plasmodium falciparum circumsporozoite protein.

Authors:  Mitsuhiro Iyori; Hiroki Nakaya; Katsuya Inagaki; Sathit Pichyangkul; Daisuke S Yamamoto; Masanori Kawasaki; Kyungtak Kwak; Masami Mizukoshi; Yoshihiro Goto; Hiroyuki Matsuoka; Makoto Matsumoto; Shigeto Yoshida
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

8.  Immunization with pre-erythrocytic antigen CelTOS from Plasmodium falciparum elicits cross-species protection against heterologous challenge with Plasmodium berghei.

Authors:  Elke S Bergmann-Leitner; Ryan M Mease; Patricia De La Vega; Tatyana Savranskaya; Mark Polhemus; Christian Ockenhouse; Evelina Angov
Journal:  PLoS One       Date:  2010-08-19       Impact factor: 3.240

9.  Identification of phosphorylated proteins in erythrocytes infected by the human malaria parasite Plasmodium falciparum.

Authors:  Yang Wu; Morag M Nelson; Andrew Quaile; Dong Xia; Jonathan M Wastling; Alister Craig
Journal:  Malar J       Date:  2009-05-18       Impact factor: 2.979

10.  Evaluation of immunoglobulin purification methods and their impact on quality and yield of antigen-specific antibodies.

Authors:  Elke S Bergmann-Leitner; Ryan M Mease; Elizabeth H Duncan; Farhat Khan; John Waitumbi; Evelina Angov
Journal:  Malar J       Date:  2008-07-14       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.